DRTS - Alpha Tau Medical Ltd
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$18.00
DETAILS
HIGH:
$30.00
LOW:
$8.00
MEDIAN:
$16.00
CONSENSUS:
$18.00
UPSIDE:
19.76%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.2 | 0 | 0 | 0 | 0 | 0.1 | 0 |
| Gross Profit | (1.2) | 0 | 0 | 0 | 0 | (0.1) | 0 |
| Operating Expenses | |||||||
| R&D Expenses | 30.8 | 27.0 | 26.4 | 20.9 | 11.4 | 7.5 | 6.6 |
| SG&A Expenses | 10.2 | 9.0 | 9.3 | 11.2 | 2.3 | 1.7 | 1.4 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 41.1 | 36.0 | 35.7 | 32.1 | 13.8 | 9.2 | 8.0 |
| Operating Income | |||||||
| Operating Income | (42.3) | (36.0) | (35.7) | (32.1) | (13.8) | (9.2) | (8.0) |
| Interest Expense | 0.4 | 0.3 | 0.1 | 0 | 0 | 0.2 | 0 |
| Interest Income | 3.8 | 4.3 | 4.8 | 1.8 | 0.2 | 0.6 | 0.8 |
| Profitability | |||||||
| EBITDA | (41.1) | (30.3) | (28.0) | (32.8) | (26.5) | (9.2) | (7.9) |
| EBIT | (42.3) | (31.4) | (29.1) | (33.7) | (27.3) | (9.2) | (8.0) |
| Income Before Tax | (42.5) | (31.7) | (29.1) | (33.7) | (27.3) | (8.7) | (8.3) |
| Income Tax Expense | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 |
| Net Income | (42.6) | (31.8) | (29.2) | (33.8) | (27.3) | (8.9) | (8.5) |
| Per Share Data | |||||||
| EPS (Basic) | -0.53 | -0.45 | -0.42 | -0.53 | -0.40 | -0.13 | -0.13 |
| EPS (Diluted) | -0.53 | -0.45 | -0.42 | -0.53 | -0.40 | -0.13 | -0.13 |
| Shares Outstanding | 80.6 | 69.9 | 69.4 | 63.5 | 67.6 | 67.6 | 67.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 16.0 | 13.7 | 12.7 | 5.8 | 23.2 | 15.6 | 1.8 |
| Short-Term Investments | 60.9 | 45.9 | 69.1 | 98.7 | 8.1 | 30.4 | 26.3 |
| Net Receivables | 0.0 | 0.3 | 0.3 | 0.0 | 0.5 | 0.5 | 0.1 |
| Inventory | 0 | 0 | 0 | 0 | (8.2) | 0 | 1.1 |
| Other Current Assets | 0 | 3.3 | 3.2 | 1.1 | 8.8 | 0.6 | (0.2) |
| Total Current Assets | 78.3 | 64.2 | 85.8 | 106.5 | 32.6 | 47.5 | 29.8 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 26.9 | 21.5 | 21.2 | 13.3 | 7.5 | 5.4 | 1.7 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.5 | 0.4 | 0.5 | 0.4 | 2.0 | 0.1 | 0.0 |
| Total Non-Current Assets | 28.3 | 22.0 | 21.6 | 13.7 | 9.6 | 5.5 | 1.7 |
| Total Assets | 106.6 | 86.2 | 107.4 | 120.1 | 42.2 | 53.0 | 31.6 |
| Current Liabilities | |||||||
| Account Payables | 3.9 | 3.5 | 2.6 | 1.4 | 1.2 | 1.0 | 0.9 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.8 | 1.5 | 1.2 | 1.3 | 2.4 | 0.6 | 0 |
| Total Current Liabilities | 10.5 | 8.7 | 7.1 | 4.3 | 4.4 | 2.1 | 1.3 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 6.4 | 5.6 | 5.6 | 0 | 54.0 | 54.0 | 0 |
| Deferred Tax Liabilities | 1.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5.4 | 3.3 | 3.6 | 5.6 | 18.6 | 5.4 | 30.4 |
| Total Non-Current Liabilities | 19.0 | 14.9 | 15.8 | 10.2 | 72.6 | 59.3 | 30.4 |
| Total Liabilities | 29.5 | 23.5 | 22.9 | 14.5 | 77.0 | 61.4 | 31.8 |
| Stockholders' Equity | |||||||
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 |
| Retained Earnings | (190.1) | (147.5) | (115.8) | (86.6) | (52.8) | (25.6) | (16.7) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | (0.1) | (0.0) |
| Total Stockholders' Equity | 77.1 | 62.7 | 84.5 | 105.7 | (34.8) | (8.4) | (0.2) |
| Total Liabilities & Equity | 106.6 | 86.2 | 107.4 | 120.1 | 42.2 | 53.0 | 31.6 |
| Debt Metrics | |||||||
| Total Debt | 13.7 | 12.5 | 13.3 | 5.2 | 54.0 | 54.0 | 0 |
| Net Debt | (2.3) | (1.2) | 0.6 | (0.6) | 30.7 | 38.4 | (1.8) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (42.6) | (31.8) | (29.2) | (33.8) | (27.3) | (8.9) | (8.5) |
| Depreciation & Amortization | 1.2 | 1.1 | 1.1 | 1.0 | 0.8 | 0.1 | 0.1 |
| Stock-Based Compensation | 0 | 9.9 | 7.9 | 6.7 | 0.8 | 0.6 | 0.5 |
| Change in Working Capital | 2.3 | 1.2 | 2.5 | (0.3) | 0.6 | 0.9 | (0.1) |
| Other Non-Cash Items | 12.4 | (0.2) | (0.3) | 2.5 | 13.3 | 0.1 | 0.0 |
| Operating Cash Flow | (26.7) | (19.8) | (18.0) | (23.9) | (11.8) | (7.3) | (6.9) |
| Investing Activities | |||||||
| Capital Expenditure | (6.1) | (2.2) | (6.4) | (0.9) | (2.9) | (3.8) | (1.3) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| Purchases of Investments | (70.5) | (125.1) | 0 | 0 | 0 | 0 | (54.3) |
| Sales/Maturities of Investments | 56.0 | 148.2 | 0 | 0 | 0 | 0 | 45.4 |
| Other Investing Activities | 0 | (0.1) | 25.1 | (89.0) | 22.2 | (4.0) | (0.0) |
| Investing Cash Flow | (20.6) | 20.8 | 18.7 | (89.9) | 19.3 | (7.8) | (10.2) |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 5.2 | 93.5 | 0 | 0 | 0.1 |
| Financing Cash Flow | 45.8 | 0.0 | 5.3 | 96.9 | 0.1 | 29.3 | 5.3 |
| Cash Position | |||||||
| Net Change in Cash | (1) | 1.2 | 9.1 | (17.2) | 7.7 | 16.2 | (11.8) |
| Cash at Beginning | 17.0 | 15.8 | 6.7 | 23.9 | 16.2 | 0 | 13.6 |
| Cash at End | 16.0 | 17.0 | 15.8 | 6.7 | 23.9 | 16.2 | 1.8 |
| Free Cash Flow | (32.8) | (22.0) | (24.4) | (24.8) | (14.7) | (11.0) | (8.2) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (1.2) | 0 | 0 | 0 | 0 | (0.1) | 0 |
| Operating Income | (42.3) | (36.0) | (35.7) | (32.1) | (13.8) | (9.2) | (8.0) |
| Net Income | (42.6) | (31.8) | (29.2) | (33.8) | (27.3) | (8.9) | (8.5) |
| EPS (Diluted) | -0.53 | -0.45 | -0.42 | -0.53 | -0.40 | -0.13 | -0.13 |
| Balance Sheet | |||||||
| Cash & Equivalents | 16.0 | 13.7 | 12.7 | 5.8 | 23.2 | 15.6 | 1.8 |
| Total Assets | 106.6 | 86.2 | 107.4 | 120.1 | 42.2 | 53.0 | 31.6 |
| Total Debt | 13.7 | 12.5 | 13.3 | 5.2 | 54.0 | 54.0 | 0 |
| Stockholders' Equity | 77.1 | 62.7 | 84.5 | 105.7 | (34.8) | (8.4) | (0.2) |
| Cash Flow | |||||||
| Operating Cash Flow | (26.7) | (19.8) | (18.0) | (23.9) | (11.8) | (7.3) | (6.9) |
| Capital Expenditure | (6.1) | (2.2) | (6.4) | (0.9) | (2.9) | (3.8) | (1.3) |
| Free Cash Flow | (32.8) | (22.0) | (24.4) | (24.8) | (14.7) | (11.0) | (8.2) |